Author/Authors
Yılmaz, Özlem Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey , Güler Özden, Müge Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey , Aydın, Fatma Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey , Şentürk, Nilgün Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey , Cantürk, Tayyar Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey , Turanlı, Ahmet Yaşar Ondokuz Mayis University - Medical Faculty - Department of Dermatology, Turkey
Title Of Article
Acneiform skin lesions associated with cetuximab therapy: Report of two cases
شماره ركورد
37795
Abstract
Cetuximab, is an IgG1 chimeric monoclonal antibody type of epidermal growth factor receptor (EGFR). It is most commonly prescribed for metastatic colorectal cancer, administered alone or in combination with irinotecan-based chemotherapy regimens (Lee et al., 2008; Segaert et al., 2005; Segaert and Cutsem 2005; Scope et al., 2009). Acneiform eruption is the most common adverse effect with 80% of incidence (Segaert and Cutsem 2005; Lee et al., 2008). We report two cases of severe acneiform eruption induced by cetuximab with metastatic colorectal cancer.
From Page
118
NaturalLanguageKeyword
Cetuximab Acneiform Eruption Colorectal Cancer Irinotecan Chemotherapy Side Effect
JournalTitle
Journal Of Experimental and Clinical Medicine
To Page
119
JournalTitle
Journal Of Experimental and Clinical Medicine
Link To Document